Association study between polymorphisms in MIA3, SELE, SMAD3 and CETP genes and coronary artery disease in an Iranian population.
Association
CAD
CETP
MIA3
Polymorphism
SELE
SMAD3
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
30 06 2022
30 06 2022
Historique:
received:
13
02
2022
accepted:
31
05
2022
entrez:
29
6
2022
pubmed:
30
6
2022
medline:
2
7
2022
Statut:
epublish
Résumé
Coronary artery disease (CAD) is the most common heart disease. Several studies have shown association between some polymorphism in different genes with CAD. Finding this association can be used in order to early diagnosis and prevention of CAD. 101 CAD patients with ≥ 50% luminal stenosis of any coronary vessel as case group and 111 healthy individuals as control group were selected. the polymorphisms were evaluated by ARMS-PCR and RFLP-PCR methods. The results of this study show that there is no significant association between rs17228212, rs17465637, and rs708272 and risk of CAD. But there is significant association between risk of CAD and rs5355 (p-value = 0.022) and rs3917406 (p-value = 0.006) in total cases, and rs5882 (p-value = 0.001) in male cases. Our findings revealed a significant interaction between CETP SNPs and CETP activity for affecting HDL-C levels. The SELE gene is a known cell adhesion molecule with a significant role in inflammation. Studies about possible linkage between SELE gene polymorphisms and the development of CAD are conflicting. We have found a significant association between polymorphisms of SELE gene and risk of CAD.
Sections du résumé
BACKGROUND
Coronary artery disease (CAD) is the most common heart disease. Several studies have shown association between some polymorphism in different genes with CAD. Finding this association can be used in order to early diagnosis and prevention of CAD.
METHOD
101 CAD patients with ≥ 50% luminal stenosis of any coronary vessel as case group and 111 healthy individuals as control group were selected. the polymorphisms were evaluated by ARMS-PCR and RFLP-PCR methods.
RESULT
The results of this study show that there is no significant association between rs17228212, rs17465637, and rs708272 and risk of CAD. But there is significant association between risk of CAD and rs5355 (p-value = 0.022) and rs3917406 (p-value = 0.006) in total cases, and rs5882 (p-value = 0.001) in male cases.
CONCLUSIONS
Our findings revealed a significant interaction between CETP SNPs and CETP activity for affecting HDL-C levels. The SELE gene is a known cell adhesion molecule with a significant role in inflammation. Studies about possible linkage between SELE gene polymorphisms and the development of CAD are conflicting. We have found a significant association between polymorphisms of SELE gene and risk of CAD.
Identifiants
pubmed: 35768776
doi: 10.1186/s12872-022-02695-6
pii: 10.1186/s12872-022-02695-6
pmc: PMC9245199
doi:
Substances chimiques
CETP protein, human
0
Cholesterol Ester Transfer Proteins
0
SMAD3 protein, human
0
Smad3 Protein
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
298Informations de copyright
© 2022. The Author(s).
Références
Cardiovasc Res. 2007 May 1;74(2):184-95
pubmed: 17109837
PLoS One. 2011 Jan 14;6(1):e14525
pubmed: 21264293
J Med Chem. 2006 Jan 12;49(1):1-22
pubmed: 16392785
Nat Immunol. 2008 Feb;9(2):194-202
pubmed: 18157133
PLoS One. 2014 Feb 12;9(2):e88118
pubmed: 24533069
Physiol Rev. 1999 Jan;79(1):181-213
pubmed: 9922371
Annu Rev Pharmacol Toxicol. 2000;40:283-94
pubmed: 10836137
Atherosclerosis. 2003 Oct;170(2):191-203
pubmed: 14612198
J Mol Cell Cardiol. 2011 Oct;51(4):600-6
pubmed: 21059352
Hypertens Res. 2012 Apr;35(4):413-7
pubmed: 22158116
Mol Diagn Ther. 2014 Apr;18(2):243-52
pubmed: 24151105
Ann Hum Genet. 2011 Jul;75(4):475-82
pubmed: 21463265
J Intern Med. 2021 Nov;290(5):980-992
pubmed: 34237186
Clin Immunol. 2008 Apr;127(1):89-97
pubmed: 18294918
Circ J. 2008 Aug;72(8):1213-7
pubmed: 18654002
Circulation. 1989 Jan;79(1):8-15
pubmed: 2642759
Curr Opin Cardiol. 2007 Jul;22(4):352-8
pubmed: 17556889
Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1710-2
pubmed: 14555638
Hum Genomics. 2012 Sep 25;6:20
pubmed: 23157875
Immunobiology. 2019 Jan;224(1):10-14
pubmed: 30501958
Coron Artery Dis. 2018 Aug;29(5):429-437
pubmed: 29652673
Kaohsiung J Med Sci. 2017 Jan;33(1):1-10
pubmed: 28088267
Mol Biol Rep. 2018 Dec;45(6):1929-1935
pubmed: 30178218
Nat Genet. 2009 Jan;41(1):56-65
pubmed: 19060906
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2045-51
pubmed: 22895665
Lipids Health Dis. 2013 Jun 08;12:85
pubmed: 23758630
J Mol Biol. 2001 Mar 16;307(1):31-7
pubmed: 11243801
Genome Med. 2009 Feb 26;1(2):28
pubmed: 19341499
J Community Genet. 2010 Jun;1(2):55-62
pubmed: 22460205
N Engl J Med. 2007 Aug 2;357(5):443-53
pubmed: 17634449
BMC Med Genet. 2014 Dec 21;15:140
pubmed: 25528061
J Mol Med (Berl). 2001 Jul;79(7):390-8
pubmed: 11466561
J Leukoc Biol. 2007 Dec;82(6):1466-72
pubmed: 17726152
Indian J Med Res. 2009 Mar;129(3):293-8
pubmed: 19491422
Nat Genet. 2006 Feb;38(2):209-13
pubmed: 16415888
Coron Artery Dis. 2005 Feb;16(1):45-50
pubmed: 15654200
BMC Med Genet. 2012 Nov 29;13:115
pubmed: 23190470
Genes Cells. 2002 Dec;7(12):1191-204
pubmed: 12485160
Gene Expr Patterns. 2004 Jul;4(4):473-9
pubmed: 15183315
DNA Cell Biol. 2012 Aug;31(8):1412-7
pubmed: 22577832
Nat Genet. 2011 Mar 06;43(4):333-8
pubmed: 21378990
PLoS One. 2014 Feb 03;9(2):e88152
pubmed: 24498435
Atherosclerosis. 2013 Nov;231(1):136-40
pubmed: 24125424
Circ Res. 2018 Feb 2;122(3):433-443
pubmed: 29212778
Int Immunopharmacol. 2013 May;16(1):1-6
pubmed: 23541743
Int J Environ Res Public Health. 2016 Sep 05;13(9):
pubmed: 27608031
Int J Cancer. 2006 Dec 15;119(12):2812-20
pubmed: 17044017
Lipids Health Dis. 2018 Apr 19;17(1):89
pubmed: 29673405
Int J Clin Exp Med. 2015 Mar 15;8(3):4387-92
pubmed: 26064358
J Cell Sci. 2001 Dec;114(Pt 24):4359-69
pubmed: 11792802
Bosn J Basic Med Sci. 2015 Feb 01;15(1):9-13
pubmed: 25725138
Arch Med Sci. 2010 Apr 30;6(2):160-7
pubmed: 22371740
Oncol Rep. 2007 Oct;18(4):885-91
pubmed: 17786351